DOCSLIB.ORG

Amphetamines, New Psychoactive Drugs and the Monoamine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Amphetamines, New Psychoactive Drugs and the Monoamine Review Amphetamines, new psychoactive drugs and the monoamine transporter cycle 1,2 1 Harald H. Sitte and Michael Freissmuth 1 Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University Vienna, Waehringerstrasse 13A, 1090 Vienna, Austria 2 Center for Addiction Research and Science (AddRess), Medical University Vienna, Waehringerstrasse 13A, 1090 Vienna, Austria In monoaminergic neurons, the vesicular transporters rule (Box 1). Hence, this large group of compounds is and the plasma membrane transporters operate in a relay. difficult to define on chemical grounds. An operational Amphetamine and its congeners target this relay to definition based on the pharmacology (‘amphetamine-like elicit their actions: most amphetamines are substrates, action’) falls short of accounting for the complex mode of which pervert the relay to elicit efflux of monoamines into action: in fact, there is a continuum ranging from amphet- the synaptic cleft. However, some amphetamines act as amine-triggered release to methylphenidate-induced transporter inhibitors. Both compound classes elicit pro- blockage of uptake. A clear-cut definition would facilitate found psychostimulant effects, which render them liable imposing legal restrictions on marketing activities. The to recreational abuse. Currently, a surge of new psycho- difficulties arising from a chemistry-based definition are active substances occurs on a global scale. Chemists also exemplified by cathinones: the naturally occurring bypass drug bans by ingenuous structural variations, cathinone is a ketone. It serves as a scaffold for numerous resulting in a rich pharmacology. A credible transport substitutions: methylation produces meth(yl)cathinone, model must account for their distinct mode of action which allows regulations restricting the sales of cathinone and link this to subtle differences in activity and unde- to be bypassed. However, cathinone derivatives are not sired, potentially deleterious effects. only used illicitly: they include the antidepressant drug bupropion and the anorectic agent diethylpropion. Syn- Amphetamines – a diverse class of compounds thetic analogs of methcathinone have recently become The amphetamines are a diverse class of chemical com- popular as ‘designer drugs’ or ‘legal highs’ on the illicit pounds. They comprise synthetic compounds and natu- drug market [4]. Often, they are referred to as ‘bath rally occurring alkaloids such as ephedrine and cathinone salts’, ‘plant food’, or ‘research chemicals’ to facilitate (Box 1), which are synthesized in the plant species Ephe- their distribution and to obviate prosecution. Popular dra and Catha, respectively. Extracts from these plants methcathinone derivatives are 4-methylmethcathinone have been used for their remedial and psychostimulant (mephedrone, Box 1) and 3,4-methylenedioxymethcathi- effects for millenia (for an excellent historical overview none (methylone). More recently, 3,4-methylenedioxypyr- see [1]). Laza˘r Edeleanu synthesized the eponymous com- rovalerone (MDPV, Box 1) has reached the market; it is pound amphetamine in Berlin in 1887 (Box 1); many an example of a very potent, psychoactive synthetic cath- derivatives were produced within the next two decades inone and illustrates the problem of a laissez-faire ap- [1]. The availability of pure compounds allowed their proach to recreational drug use: MDPV exerts stimulant- pharmacological characterization, which was initiated like effects at low doses, but life-threatening side effects by Sir Henry Dale [2]. Biel and Bopp [3] chemically are seen at high doses or upon chronic use [5]. Accordingly, defined an amphetamine as containing: (i) an unsubsti- the authorities have banned amphetamines including tuted phenyl ring, (ii) a two-carbon side chain between the the first-generation synthetic cathinones such as mephe- phenyl ring and nitrogen, (iii) an a-methyl group, and (iv) drone, methylone, and MDPV in the USA and the EU. a primary amino group (Box 1). Many compounds meet Ignorance is blatant with respect to new psychoactive these criteria. In addition, the targets (i.e., the mono- substances (NPS) which flood the drug market at present amine transporters) apparently interpret the rules in a (Box 2). Chemical substitutions may render a given drug flexible manner: for instance, methamphetamine, ephed- compatible with current legislation, but they may also rine, and methylphenidate violate the primary-amine introduce dramatic changes in the activity of the com- pound and in its mode of action. Widespread consumption Corresponding author: Sitte, H.H. ([email protected]). Keywords: psychostimulant; amphetamine; reverse transport; regulation; monoa- of NPS may be associated with health risks such as mine transporter; addiction. neurodegeneration. These are linked – at least in part 0165-6147/ – to the mode of action. Accordingly, it is of relevance to ß 2014 The Authors. Published by Elsevier Ltd. This is an open access article under elucidate the different modes of action of amphetamine, the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). http://dx.doi.org/10.1016/j.tips.2014.11.006 its congeners, and in particular of stimulant NPS. The Trends in Pharmacological Sciences, January 2015, Vol. 36, No. 1 41 Review Trends in Pharmacological Sciences January 2015, Vol. 36, No. 1 Box 1. Structural differences between amphetamines The chemical definition by Biel and Bopp [3] posits the presence of receptors [75]. Moreover, the individual structural differences (i) an unsubstituted phenyl ring, (ii) a two-carbon side chain between between the different amphetamines highlight the specificity the phenyl ring and a nitrogen, (iii) an a-methyl group, and (iv) a between monoamine transporters, for example the SERT over DAT primary amino group in a compound to qualify as an amphetamine selectivity of pCA and fenfluramine [1,76], or the DAT-preference of (Figure I). Panel (A) illustrates this rule. Panel (B) shows the trace D-amphetamine [75]. However, amphetamines also bind to non- amine phenethylamine which is produced in higher organisms, monoamine transporter targets such as adrenergic receptors [1] or while panels (C,D) show the structures of the plant alkaloids trace amine receptors [77]. These receptors form complexes with ephedrine and cathinone. Panels (E–I) show the structural diversity transporters [78]; trace amine-associated receptor (TAR) agonists in amphetamines, which either conform to (E) or violate the chemical (including amphetamines) inhibit uptake [79,80]. These observations definition of Biel and Bopp rule (F–I). Accordingly, amphetamines point to a possible role of TARs in the treatment of amphetamine are a diverse group of compounds that target the transporters for addiction. The compound structures are reproduced from the monoamine neurotransmitters, but do not engage their cognate PubChem database. (a) (b) (c) (4) H H H H N N H N H (2) C C O (1) (3) Basic chemistry Phenethylamine Ephedrine (d) H H (e) H H (f) N N H N O Cathinone D-amphetamine Methamphetamine (g) (h) (i) H N O O N O N HH H O O O 3,4-Methylene- Methylphenidate Mephedrone dioxypyrovalerone TRENDS in Pharmacological Sciences Figure I. Chemical structures of amphetamines. main targets of amphetamines (and presumably of many amphetamine has been studied for more than 100 years stimulant NPS) are the neurotransmitter:sodium sym- [2]. Nevertheless, there are still many open questions: (i) porters (NSS) for the monoamines dopamine (DAT/solute how do these compounds differ from physiological sub- carrier protein SLC6A3), serotonin (SERT/SLC6A4), and strates to act as efficient releasers? (ii) What is the role of noradrenaline/norepinephrine (NET/SLC6A2). Ampheta- protein kinases in triggering efflux? (iii) Does the oligo- mines are exogenous substrates of and generate a meric arrangement of monoamine transporters affect current through these transporters [6]. The action of the action of amphetamine? (iv) Why does amphetamine 42 Review Trends in Pharmacological Sciences January 2015, Vol. 36, No. 1 Box 2. New psychoactive substances: scrutinizing their mode of action The term ‘new psychoactive substances’ (NPS) refers to a wide variety initiate transporter-mediated monoamine efflux (i.e., reverse transport of compounds which elicit psychotomimetic effects. These drugs or release), whereas blockers do not. Importantly, amphetamine- include stimulants that are congeners of amphetamine or synthetic associated depolarization puts neurons at risk: in fact, the use of cathinones. Their street market names ‘designer drugs’, ‘bath salts’, fenfluramines has been associated not only with neuronal depletion of ‘plant food’, or ‘research chemicals’ imply an innocuous recreational 5-HT [76], but also with pulmonary hypertension and valvular heart consumption. However, NPS is not restricted to compounds that act like disease [83]. The latter arises from the long-term effect of serotonin on amphetamine: also cannabimimetics, sedative-hypnotics, and also the pulmonary vasculature. hallucinogens such as 2-CB (2,5-dimethoxy-4-bromophenethylamine), Two simple diagnostic assays can be employed to assess the nature a partial agonist at 5HT2A-receptors, and related receptor ligands are of the compound under scrutiny: (i) electrophysiological recording of also classified as NPS [81]. NPS are not harmless: 4-methyl-N- transport-associated currents and/or (ii) examination of the initiation methylcathinone (mephedrone) and 3,4-methylenedioxypyrrovalerone of reverse
Load more

Recommended publications
  • Neurotransmitter Resource Guide
    NEUROTRANSMITTER RESOURCE GUIDE Science + Insight doctorsdata.com Doctor’s Data, Inc. Neurotransmitter RESOURCE GUIDE Table of Contents Sample Report Sample Report ........................................................................................................................................................................... 1 Analyte Considerations Phenylethylamine (B-phenylethylamine or PEA) ................................................................................................. 1 Tyrosine .......................................................................................................................................................................................... 3 Tyramine ........................................................................................................................................................................................4 Dopamine .....................................................................................................................................................................................6 3, 4-Dihydroxyphenylacetic Acid (DOPAC) ............................................................................................................... 7 3-Methoxytyramine (3-MT) ............................................................................................................................................... 9 Norepinephrine ........................................................................................................................................................................
    [Show full text]
  • Methylphenidate Hydrochloride
    Application for Inclusion to the 22nd Expert Committee on the Selection and Use of Essential Medicines: METHYLPHENIDATE HYDROCHLORIDE December 7, 2018 Submitted by: Patricia Moscibrodzki, M.P.H., and Craig L. Katz, M.D. The Icahn School of Medicine at Mount Sinai Graduate Program in Public Health New York NY, United States Contact: [email protected] TABLE OF CONTENTS Page 3 Summary Statement Page 4 Focal Point Person in WHO Page 5 Name of Organizations Consulted Page 6 International Nonproprietary Name Page 7 Formulations Proposed for Inclusion Page 8 International Availability Page 10 Listing Requested Page 11 Public Health Relevance Page 13 Treatment Details Page 19 Comparative Effectiveness Page 29 Comparative Safety Page 41 Comparative Cost and Cost-Effectiveness Page 45 Regulatory Status Page 48 Pharmacoepial Standards Page 49 Text for the WHO Model Formulary Page 52 References Page 61 Appendix – Letters of Support 2 1. Summary Statement of the Proposal for Inclusion of Methylphenidate Methylphenidate (MPH), a central nervous system (CNS) stimulant, of the phenethylamine class, is proposed for inclusion in the WHO Model List of Essential Medications (EML) & the Model List of Essential Medications for Children (EMLc) for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) under ICD-11, 6C9Z mental, behavioral or neurodevelopmental disorder, disruptive behavior or dissocial disorders. To date, the list of essential medications does not include stimulants, which play a critical role in the treatment of psychotic disorders. Methylphenidate is proposed for inclusion on the complimentary list for both children and adults. This application provides a systematic review of the use, efficacy, safety, availability, and cost-effectiveness of methylphenidate compared with other stimulant (first-line) and non-stimulant (second-line) medications.
    [Show full text]
  • Is TAAR1 a Potential Therapeutic Target for Immune Dysregulation In
    Graduate Physical and Life Sciences PhD Pharmacology Abstract ID# 1081 Is TAAR1 a Potential Therapeutic Target for Immune Dysregulation in Drug Abuse? Fleischer, Lisa M; Tamashunas, Nina and Miller, Gregory M Addiction Sciences Laboratory, Northeastern University, Boston MA 02115 Abstract Discovered in 2001, Trace Amine Associated Receptor 1 (TAAR1) is a direct target of Data and Results amphetamine, methamphetamine and MDMA. It is expressed in the brain reward circuity and modulates dopamine transporter function and dopamine neuron firing rates. Newly-developed compounds that specifically target TAAR1 have recently been investigated in animal models In addition to brain, TAAR1 is expressed in immune cells METH promotes PKA and PKC Phosphorylation through TAAR1 as candidate therapeutics for methamphetamine, cocaine and alcohol abuse. These studies • We treated HEK/TAAR1 cells and HEK293 involving classic behavioral measures of drug response, as well as drug self-administration, Rhesus and Human cells with vehicle or METH, with and without strongly implicate TAAR1 as a potential therapeutic target for the treatment of addiction. In activators and inhibitors of PKA and PKC. addition to its central actions, we demonstrated that TAAR1 is upregulated in peripheral blood Cells Lines mononuclear cells (PBMC) and B cells following immune activation, and that subsequent • We performed Western blotting experiments to activation of TAAR1 by methamphetamine stimulates cAMP, similar to the function of measure levels of phospho-PKA and phospho- adenosine A2 receptors which are also present in immune cells and play a critical role in the PKC. immune response. Here, we are investigating the relationship between TAAR1 and the • We found that specific activators of PKA and adenosine A2 receptor at the level of cellular signaling and receptor dimerization.
    [Show full text]
  • Comparison of the Characteristic Mass Fragmentations of Phenethylamines and Tryptamines by Electron Ionization Gas Chromatograph
    applied sciences Article Comparison of the Characteristic Mass Fragmentations of Phenethylamines and Tryptamines by Electron Ionization Gas Chromatography Mass Spectrometry, Electrospray and Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Bo-Hong Chen, Ju-Tsung Liu, Hung-Ming Chen, Wen-Xiong Chen and Cheng-Huang Lin * Department of Chemistry, National Taiwan Normal University, 88 Sec. 4 Tingchow Road, Taipei 11677, Taiwan; [email protected] (B.-H.C.); [email protected] (J.-T.L.); [email protected] (H.-M.C.); [email protected] (W.-X.C.) * Correspondence: [email protected]; Tel.: +886-2-7734-6170; Fax: +886-2-2932-4249 Received: 18 April 2018; Accepted: 19 June 2018; Published: 22 June 2018 Abstract: Characteristic mass fragmentation of 20 phenethylamine/tryptamine standards were investigated and compared by means of matrix assisted laser desorption/time-of-flight mass spectrometry (MALDI/TOFM), gas chromatography–electron ionization–mass spectrometry (GC-EI/MS) and liquid chromatography–electrospray ionization/mass spectrometry (LC-ESI/MS) + methods. As a result, three characteristic peaks ([M] and fragments from the Cβ-Cα bond breakage) were found to be unique and contained information useful in identifying 2C series compounds based on the GC-EI/MS method. We found that the protonated molecular ion ([M+H]+) and two types of fragments produced from the α-cleavage and β-cleavage processes were useful mass spectral information in the rapid screening and confirmation of phenethylamine and tryptamine derivatives when ESI/MS and MALDI/TOFMS methods were applied. This assay was successfully used to determine samples that contain illicit drugs. Keywords: phenethylamine; tryptamine; MALDI/TOFMS; GC-EI/MS; LC-ESI/MS 1.
    [Show full text]
  • Effects of the Trace Amine Associated Receptor 1 Agonist RO5263397 On
    International Journal of Neuropsychopharmacology, 2015, 1–7 doi:10.1093/ijnp/pyu060 Research Article research article Effects of the Trace Amine Associated Receptor 1 Agonist RO5263397 on Abuse-Related Behavioral Indices of Methamphetamine in Rats Li Jing, PhD; Yanan Zhang, PhD; Jun-Xu Li, PhD Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (Drs Jing and Li); Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China (Dr Jing); Research Triangle Institute, Research Triangle Park, NC (Dr Zhang). Correspondence: Jun-Xu Li, PhD, Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY ([email protected]). Abstract Background: Methamphetamine is a major drug of abuse with no effective pharmacotherapy available. Trace amine associated receptor 1 is implicated in cocaine addiction and represents a potential therapeutic target. However, the effects of trace amine associated receptor 1 agonists on addiction-related behavioral effects of methamphetamine are unknown. Methods: This study examined the effects of a trace amine associated receptor 1 agonist RO5263397 on methamphetamine- induced behavioral sensitization, methamphetamine self-administration, cue- and methamphetamine-induced reinstatement of drug seeking, and cue-induced reinstatement of sucrose-seeking behaviors in rats. Male Sprague-Dawley rats were used to examine the effects of methamphetamine alone and in combination with the trace amine associated receptor 1 agonist RO5263397 (3.2–10 mg/kg). Results: RO5263397 dose-dependently attenuated the expression of behavioral sensitization to methamphetamine, reduced methamphetamine self-administration, and decreased both cue- and a priming dose of methamphetamine-induced reinstatement of drug-seeking behaviors.
    [Show full text]
  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors.
    [Show full text]
  • Tyramine and Amyloid Beta 42: a Toxic Synergy
    biomedicines Article Tyramine and Amyloid Beta 42: A Toxic Synergy Sudip Dhakal and Ian Macreadie * School of Science, RMIT University, Bundoora, VIC 3083, Australia; [email protected] * Correspondence: [email protected]; Tel.: +61-3-9925-6627 Received: 5 May 2020; Accepted: 27 May 2020; Published: 30 May 2020 Abstract: Implicated in various diseases including Parkinson’s disease, Huntington’s disease, migraines, schizophrenia and increased blood pressure, tyramine plays a crucial role as a neurotransmitter in the synaptic cleft by reducing serotonergic and dopaminergic signaling through a trace amine-associated receptor (TAAR1). There appear to be no studies investigating a connection of tyramine to Alzheimer’s disease. This study aimed to examine whether tyramine could be involved in AD pathology by using Saccharomyces cerevisiae expressing Aβ42. S. cerevisiae cells producing native Aβ42 were treated with different concentrations of tyramine, and the production of reactive oxygen species (ROS) was evaluated using flow cytometric cell analysis. There was dose-dependent ROS generation in wild-type yeast cells with tyramine. In yeast producing Aβ42, ROS levels generated were significantly higher than in controls, suggesting a synergistic toxicity of Aβ42 and tyramine. The addition of exogenous reduced glutathione (GSH) was found to rescue the cells with increased ROS, indicating depletion of intracellular GSH due to tyramine and Aβ42. Additionally, tyramine inhibited the respiratory growth of yeast cells producing GFP-Aβ42, while there was no growth inhibition when cells were producing GFP. Tyramine was also demonstrated to cause increased mitochondrial DNA damage, resulting in the formation of petite mutants that lack respiratory function.
    [Show full text]
  • N-Alkylation of Phenethylamine and Tryptamine Gerta Cami-Kobeci, Paul A
    Bioorganic & Medicinal Chemistry Letters 15 (2005) 535–537 N-Alkylation of phenethylamine and tryptamine Gerta Cami-Kobeci, Paul A. Slatford, Michael K. Whittlesey and Jonathan M. J. Williams* Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK Received 28 October 2004; revised 17 November 2004; accepted 18 November 2004 Available online 24 December 2004 Abstract—A clean and efficient method for the N-alkylation of tryptamine and phenethylamine, employing alcohols as the alkyl- ating agents, has been developed. The reaction proceeds via catalytic electronic activation, involving an iridium catalyst which activates the alcohol by borrowing hydrogen from the substrate, returning it later in the catalytic cycle. Some examples of N-heterocyclisation have been performed employing a diol as the substrate. Ó 2004 Elsevier Ltd. All rights reserved. The ability to prepare a large number of synthetically NMe2 useful and pharmacologically active compounds, either H N OH by traditional or high throughput methods, is becoming Me S O O HN increasingly important. Herein we report an efficient, N atom economic, one-pot method for the N-alkylation H of tryptamine and phenethylamine, giving water as the OH only by-product. Sumatriptan Nylidrin Figure 1. The tryptamine sub-structure is present in numerous naturally occurring and synthetic compounds, many of which exhibit important pharmacological activity. For mercially available iminophosphorane 3.5 The reaction example, a number of 5-alkyltryptamine derivatives proceeds via a strategy
    [Show full text]
  • File Download
    Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord Elizabeth A. Gozal, Emory University Brannan E. O'Neill, Emory University Michael A. Sawchuk, Emory University Hong Zhu, Emory University Mallika Halder, Emory University Chou Ching-Chieh , Emory University Shawn Hochman, Emory University Journal Title: Frontiers in Neural Circuits Volume: Volume 8 Publisher: Frontiers | 2014-11-07, Pages 134-134 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.3389/fncir.2014.00134 Permanent URL: https://pid.emory.edu/ark:/25593/mr95r Final published version: http://dx.doi.org/10.3389/fncir.2014.00134 Copyright information: © 2014 Gozal, O'Neill, Sawchuk, Zhu, Halder, Chou and Hochman. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits distribution of derivative works, making multiple copies, distribution, public display, and publicly performance, provided the original work is properly cited. This license requires credit be given to copyright holder and/or author, copyright and license notices be kept intact. Accessed September 27, 2021 11:18 AM EDT ORIGINAL RESEARCH ARTICLE published: 07 November 2014 NEURAL CIRCUITS doi: 10.3389/fncir.2014.00134 Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord Elizabeth A. Gozal , Brannan E. O’Neill , Michael A. Sawchuk , Hong Zhu , Mallika Halder , Ching-Chieh Chou and Shawn Hochman* Physiology Department, Emory University, Atlanta, GA, USA Edited by: The trace amines (TAs), tryptamine, tyramine, and β-phenylethylamine, are synthesized Brian R.
    [Show full text]
  • Detection of Phenethylamine, Amphetamine, and Tryptamine Imine By-Products from an Acetone Extraction
    Detection of Phenethylamine, Amphetamine, and Tryptamine Imine By-Products from an Acetone Extraction Mary A. Yohannan* and Arthur Berrier U.S. Department of Justice Drug Enforcement Administration Special Testing and Research Laboratory 22624 Dulles Summit Court Dulles, VA 20166 [email: mary.a.yohannan -at- usdoj.gov] ABSTRACT: The formation of imine by-products from phenethylamines, amphetamines, and tryptamines upon an acetone extraction is presented. These imine by-products were characterized using GC/MSD and exhibited preferential cleavage at the α-carbon of the alkyl chain. Further characterization of the imine by-products of phenethylamine and tryptamine was done using IR and NMR. KEYWORDS: phenethylamine, tryptamine, imine, acetone, schiff base, drug chemistry, forensic chemistry In most forensic laboratories, the solvents used to extract at the α-carbon on the alkyl chain. In addition to GC/MS, the drugs are chosen based upon their solubility properties and their imines formed from phenethylamine base and tryptamine base ability to not interact with the drug. In fact, there are very few were characterized by Fourier transform-infrared spectroscopy publications where a solvent used to extract a drug reacts with (FTIR) and nuclear magnetic resonance (NMR) spectroscopy. the drug and forms by-products [1-3]. This laboratory recently discovered that an additional Experimental component was formed when acetone was used to extract a Solvents, Chemicals, and Materials sample containing a known tryptamine. Analysis by gas Acetone was ACS/HPLC grade from Burdick and Jackson chromatography/mass spectroscopy (GC/MS) of the acetone Laboratories (Muskegon, MI). Phenethylamine base and extract yielded an extra peak in the total ion chromatogram that tryptamine base were obtained from Sigma-Aldrich Chemicals was approximately half the abundance of the known tryptamine (Milwaukee, WI).
    [Show full text]
  • Recommended Methods for the Identification and Analysis Of
    Vienna International Centre, P.O. Box 500, 1400 Vienna, Austria Tel: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org RECOMMENDED METHODS FOR THE IDENTIFICATION AND ANALYSIS OF AMPHETAMINE, METHAMPHETAMINE AND THEIR RING-SUBSTITUTED ANALOGUES IN SEIZED MATERIALS (revised and updated) MANUAL FOR USE BY NATIONAL DRUG TESTING LABORATORIES Laboratory and Scientific Section United Nations Office on Drugs and Crime Vienna RECOMMENDED METHODS FOR THE IDENTIFICATION AND ANALYSIS OF AMPHETAMINE, METHAMPHETAMINE AND THEIR RING-SUBSTITUTED ANALOGUES IN SEIZED MATERIALS (revised and updated) MANUAL FOR USE BY NATIONAL DRUG TESTING LABORATORIES UNITED NATIONS New York, 2006 Note Mention of company names and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. ST/NAR/34 UNITED NATIONS PUBLICATION Sales No. E.06.XI.1 ISBN 92-1-148208-9 Acknowledgements UNODC’s Laboratory and Scientific Section wishes to express its thanks to the experts who participated in the Consultative Meeting on “The Review of Methods for the Identification and Analysis of Amphetamine-type Stimulants (ATS) and Their Ring-substituted Analogues in Seized Material” for their contribution to the contents of this manual. Ms. Rosa Alis Rodríguez, Laboratorio de Drogas y Sanidad de Baleares, Palma de Mallorca, Spain Dr. Hans Bergkvist, SKL—National Laboratory of Forensic Science, Linköping, Sweden Ms. Warank Boonchuay, Division of Narcotics Analysis, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand Dr. Rainer Dahlenburg, Bundeskriminalamt/KT34, Wiesbaden, Germany Mr. Adrian V. Kemmenoe, The Forensic Science Service, Birmingham Laboratory, Birmingham, United Kingdom Dr. Tohru Kishi, National Research Institute of Police Science, Chiba, Japan Dr.
    [Show full text]
  • Food Sources and Biomolecular Targets of Tyramine
    Special Article Food sources and biomolecular targets of tyramine Gaby Andersen, Patrick Marcinek, Nicole Sulzinger, Peter Schieberle, and Dietmar Krautwurst Tyramine is a biogenic trace amine that is generated via the decarboxylation of the amino acid tyrosine. At pico- to nanomolar concentrations, it can influence a multi- tude of physiological mechanisms, exhibiting neuromodulatory properties as well as cardiovascular and immunological effects. In humans, the diet is the primary Downloaded from https://academic.oup.com/nutritionreviews/article/77/2/107/5084469 by guest on 24 September 2021 source of physiologically relevant tyramine concentrations, which are influenced by a large number of intrinsic and extrinsic factors. Among these factors are the avail- ability of tyrosine in food, the presence of tyramine-producing bacteria, the environ- mental pH, and the salt content of food. The process of fermentation provides a particularly good source of tyramine in human nutrition. Here, the potential impact of dietary tyramine on human health was assessed by compiling quantitative data on the tyramine content in a variety of foods and then conducting a brief review of the literature on the physiological, cellular, and systemic effects of tyramine. Together, the data sets presented here may allow both the assessment of tyramine concentrations in food and the extrapolation of these concentrations to gauge the physiological and systemic effects in the context of human nutrition. INTRODUCTION presence of tyramine in a variety of foods, (2) the post- prandial physiological and adverse effects of tyramine, Tyramine is a biogenic amine generated via the decar- and (3) the biomolecular targets of tyramine. It is not boxylation of the amino acid tyrosine in animals, plants, intended to be a systematic or comprehensive review of and microorganisms.
    [Show full text]